Cardiac adiposity as a modulator of cardiovascular disease in HIV-Reference-Cited by-同舟云学术

Cardiac adiposity as a modulator of cardiovascular disease in HIV

Published:2021-09-12 Issue:10 Volume:22 Page:879-891
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Bonou Maria¹,Kapelios Chris J.¹^ORCID,Protogerou Athanase D.²,Mavrogeni Sophie³,Aggeli Constantina⁴,Markousis‐Mavrogenis George³,Psichogiou Mina⁵,Barbetseas John¹

Affiliation:

1. Department of Cardiology Laiko General Hospital Athens Greece

2. Cardiovascular Prevention & Research Unit, Clinic and Laboratory of Pathophysiology National and Kapodistrian University Athens School of Medicine Athens Greece

3. Department of Cardiology Onassis Cardiac Surgery Center Athens Greece

4. First Department of Cardiology Hippokration General Hospital National and Kapodistrian University Athens School of Medicine Athens Greece

5. First Department of Internal Medicine Laiko General Hospital National and Kapodistrian University Athens School of Medicine Athens Greece

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13166

Reference78 articles.

1. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association

2. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV

3. Mechanisms of Cardiovascular Disease in the Setting of HIV Infection

4. Imaging modalities for cardiovascular phenotyping in asymptomatic people living with HIV

5. Cardiomyopathy and Heart Failure in Patients With HIV Infection

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparative Study on the Presence and Reversibility of Subclinical Arterial Damage in HCV-Infected Individuals and Matched Controls;Viruses;2023-06-15

2. Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years;Postgraduate Medicine;2022-06-07